News & Events
Advancing Personalized Anti-Cancer Drugs
Researchers at Rensselaer Polytechnic Institute and Albany Medical Center are working together to develop three-dimensional bioprinting and imaging techniques that will generate and analyze tumor models in the laboratory, with the goal of accelerating the development and optimization of personalized anti-cancer drugs.
Understanding Heart Disease
The Center for Biotechnology and Interdisciplinary Studies was buzzing with activity over the summer, with more than 200 undergraduate and graduate students conducting research that will impact the global challenges facing humanity. In the lab of Douglas Swank, associate professor of biological sciences, researchers are using Drosophila (commonly known as the fruit fly) as a model organism to unravel some of the biggest mysteries of the human heart.
Confronting Dementia From Lab to Bedside
To bolster the connections between benchside and bedside, the National Institutes of Health National Institute on Aging has awarded Rensselaer Polytechnic Institute a five-year $1.5 million training grant to support a new Alzheimer’s Disease Clinical and Translational Research Training Program.
Research Showcase Focuses on Biotechnology and Life Sciences
The fourth annual Rensselaer Research Showcase on August 23 offered government and private sector research partners an opportunity to learn more about insights emerging from research in biotechnology and the life sciences, and the current climate for the biopharmaceutical economy that work supports.
Rensselaer To Welcome Class of 2021
This weekend, 1,682 new students will make their way to Rensselaer to start the next stage of their academic careers.
Bacteria Make Natural Pigment From Simple Sugar
Researchers at Rensselaer Polytechnic Institute have shown that four strains of E. coli bacteria working together can convert sugar into the natural red anthocyanin pigment found in strawberries, opening the door to economical natural colors for industrial applications.
Research Uncovers a Novel Mechanism of Common Anesthetic Propofol
Researchers at Rensselaer Polytechnic Institute and the University of Pennsylvania found that the anesthetic propofol inhibits the activity of kinesins, a class of motor proteins that provides critical services within a cell.
Rensselaer Professor Edmund Palermo Receives NSF CAREER Award
Edmund F. Palermo, assistant professor of materials science and engineering at Rensselaer Polytechnic Institute, has won a Faculty Early Career Development Award (CAREER) from the National Science Foundation (NSF). He will use the five-year, $539,177 award to study “Biomimetic Macromolecules at the Materials-Microbe Interface.”
A Moldable Scaffold for Bone
A team including researchers at Rensselaer Polytechnic Institute is developing a bioactive foam that can be used to replace skull bone lost to injury, surgery, or birth defect.
Proteins That Can Take the Heat
Ancient proteins may offer clues on how to engineer proteins that can withstand the high temperatures required in industrial applications, according to new research published in the Proceedings of the National Academy of Science.
Graduate Engineering Programs Ranked 39th in the Nation
The graduate programs in engineering at Rensselaer Polytechnic Institute are once again considered among the best in the United States, according to the U.S. News & World Report Best Graduate Schools rankings released last week. For the third year in a row Rensselaer’s graduate engineering programs have been ranked 39th in the nation.
Biomedical Engineering Graduate Students Receive Spinal Cord Injury Fellowships
Two doctoral students in biomedical engineering at Rensselaer, Anthony D’Amato and Christopher Johnson, have been awarded New York State Department of Health Spinal Cord Injury Research Board Predoctoral Fellowships.